Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment

Amr Alderawi (Wolverhampton, United Kingdom), Amr Alderawi, Simon Dunmore, Gaetano Caramori, Andrew Hitchings, Emma Baker, Paul Kirkham

Source: International Congress 2015 – New insights into lung disease pathogenesis
Session: New insights into lung disease pathogenesis
Session type: Thematic Poster Session
Number: 886
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Amr Alderawi (Wolverhampton, United Kingdom), Amr Alderawi, Simon Dunmore, Gaetano Caramori, Andrew Hitchings, Emma Baker, Paul Kirkham. Fructosamine-3-Kinase: A molecular link between COPD and diabetes regulating carbonyl stress and the impact of metformin treatment. Eur Respir J 2015; 46: Suppl. 59, 886

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016

L-arginine pathway metabolites can predict exacerbation independently from beta blocker treatment in patients with COPD: A follow-up study
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013


Metabolic regulation during the co-existence of COPD and DM type2
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


The novel myokine irisin interacts with hyaluronic acid in a cell-specific way and in association with COPD progression and severity
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016

Phenotypic comparison of glucose and cardiac physiology of biomass fuel induced and smoking induced COPD
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Is there a strong relationship between COPD and cardiovascular diseases?
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013

MUC1-CT mediates corticosteroid responses in COPD
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Cytotoxic activity and oxidative DNA damage in smoking asthmatics versus COPD patients
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015


COPD, cognition and vascular inflammation: Interrelation
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013


Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013

Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

Genes, intervention and molecular mechanisms in COPD
Source: Annual Congress 2007 - Physiological year in review
Year: 2007


Bronchodiator therapy in COPD: physiological effects
Source: Breathe 2008; 4: 342-344
Year: 2008

COPD specific comorbidities: A prospective, objective and controlled evaluation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Asthma and diabetes type 2 and their co-existence: Possible changes in lung function and their importance
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

High prevalence of altered cardiac repolarization in patients with COPD
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013